WO2011120904A3 - A fast dissolving pharmaceutical composition - Google Patents
A fast dissolving pharmaceutical composition Download PDFInfo
- Publication number
- WO2011120904A3 WO2011120904A3 PCT/EP2011/054699 EP2011054699W WO2011120904A3 WO 2011120904 A3 WO2011120904 A3 WO 2011120904A3 EP 2011054699 W EP2011054699 W EP 2011054699W WO 2011120904 A3 WO2011120904 A3 WO 2011120904A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical composition
- fast dissolving
- dissolving pharmaceutical
- matrix network
- open matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/04—Evacuating, pressurising or gasifying filled containers or wrappers by means of nozzles through which air or other gas, e.g. an inert gas, is withdrawn or supplied
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/04—Methods of, or means for, filling the material into the containers or receptacles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B63/00—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
- B65B63/08—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for heating or cooling articles or materials to facilitate packaging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
- B65D75/367—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed and forming several compartments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Mechanical Engineering (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Composite Materials (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012011205A MX341200B (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition. |
RU2012141140/15A RU2566269C2 (en) | 2010-03-29 | 2011-03-28 | Fast-dissolving pharmaceutical composition |
CN201180017614.5A CN102834091B (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
EP11711321.7A EP2552418B1 (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
ES11711321.7T ES2643087T3 (en) | 2010-03-29 | 2011-03-28 | Quick Dissolve Pharmaceutical Composition |
KR1020127027214A KR101790188B1 (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
JP2013501780A JP5736031B2 (en) | 2010-03-29 | 2011-03-28 | Fast-dissolving pharmaceutical composition |
AU2011234637A AU2011234637B2 (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
BR112012024432A BR112012024432A2 (en) | 2010-03-29 | 2011-03-28 | fast dissolving pharmaceutical composition |
NZ602442A NZ602442A (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
PL11711321T PL2552418T3 (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
MX2016007895A MX350447B (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition. |
CA2793485A CA2793485A1 (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
US13/636,758 US8946153B2 (en) | 2010-03-29 | 2011-03-28 | Fast dissolving pharmaceutical composition |
IL222087A IL222087A (en) | 2010-03-29 | 2012-09-23 | Fast dissolving pharmaceutical composition |
ZA2012/07175A ZA201207175B (en) | 2010-03-29 | 2012-09-25 | A fast dissolving pharmaceutical composition |
US13/952,084 US9096335B2 (en) | 2010-03-29 | 2013-07-26 | Fast dissolving pharmaceutical composition |
US14/571,883 US10023335B2 (en) | 2010-03-29 | 2014-12-16 | Fast dissolving pharmaceutical composition |
IL247079A IL247079A0 (en) | 2010-03-29 | 2016-08-02 | A fast dissolving pharmaceutical composition |
US16/010,412 US20180297728A1 (en) | 2010-03-29 | 2018-06-16 | Fast dissolving pharmaceutical composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN743DE2010 | 2010-03-29 | ||
IN743/DEL/2010 | 2010-03-29 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/636,758 A-371-Of-International US8946153B2 (en) | 2010-03-29 | 2011-03-28 | Fast dissolving pharmaceutical composition |
US13/952,084 Division US9096335B2 (en) | 2010-03-29 | 2013-07-26 | Fast dissolving pharmaceutical composition |
US14/571,883 Continuation US10023335B2 (en) | 2010-03-29 | 2014-12-16 | Fast dissolving pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011120904A2 WO2011120904A2 (en) | 2011-10-06 |
WO2011120904A3 true WO2011120904A3 (en) | 2012-05-10 |
Family
ID=44169174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2011/054699 WO2011120904A2 (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
Country Status (19)
Country | Link |
---|---|
US (4) | US8946153B2 (en) |
EP (1) | EP2552418B1 (en) |
JP (1) | JP5736031B2 (en) |
KR (1) | KR101790188B1 (en) |
CN (2) | CN102834091B (en) |
AR (1) | AR080735A1 (en) |
AU (1) | AU2011234637B2 (en) |
BR (1) | BR112012024432A2 (en) |
CA (1) | CA2793485A1 (en) |
ES (1) | ES2643087T3 (en) |
IL (2) | IL222087A (en) |
MX (2) | MX350447B (en) |
NZ (3) | NZ619857A (en) |
PL (1) | PL2552418T3 (en) |
RU (1) | RU2566269C2 (en) |
SA (1) | SA111320320B1 (en) |
TW (1) | TWI498132B (en) |
WO (1) | WO2011120904A2 (en) |
ZA (1) | ZA201207175B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
CN102834091B (en) * | 2010-03-29 | 2015-04-22 | 辉凌公司 | A fast dissolving pharmaceutical composition |
JO3112B1 (en) * | 2010-03-29 | 2017-09-20 | Ferring Bv | A fast dissolving pharmaceutical composition |
NZ620897A (en) * | 2011-09-16 | 2016-07-29 | Ferring Bv | A fast dissolving pharmaceutical composition |
CA2878784A1 (en) * | 2012-07-12 | 2014-01-16 | Ferring B.V. | Diclofenac formulations |
TW201422254A (en) * | 2012-11-21 | 2014-06-16 | Ferring Bv | Composition for immediate and extended release |
WO2015063602A1 (en) | 2013-10-29 | 2015-05-07 | Ferring B.V. | Desmopressin and blood glucose |
US20180185293A1 (en) * | 2015-07-07 | 2018-07-05 | Toa Pharmaceutical Co., Ltd. | Bacteria-Containing Oral Rapidly Disintegrating Tablet |
US10172833B2 (en) | 2015-08-11 | 2019-01-08 | Insys Development Company, Inc. | Sublingual ondansetron spray |
WO2017075554A1 (en) * | 2015-10-29 | 2017-05-04 | Golfetto Michael | Methods freeze drying and composite materials |
MY195591A (en) * | 2017-01-11 | 2023-02-02 | Ferring Bv | A Fast Disintegrating Pharmaceutical Composition |
EP4140477A1 (en) | 2018-10-15 | 2023-03-01 | Aprecia Pharmaceuticals LLC | Method and system for forming a dosage form within a packaging |
CN113750058B (en) * | 2020-06-01 | 2023-07-04 | 北京九能天远科技有限公司 | Phloroglucinol freeze-dried orally disintegrating tablet and preparation method thereof |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
CN114010609A (en) * | 2021-11-23 | 2022-02-08 | 莱默(北京)药业科技有限公司 | Montelukast sodium freeze-dried orally disintegrating tablet and preparation method thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6509040B1 (en) * | 2001-06-22 | 2003-01-21 | R.P. Scherer Corporation | Fast dispersing dosage forms essentially free of mammalian gelatin |
EP1308171A1 (en) * | 2000-07-13 | 2003-05-07 | Daiichi Pharmaceutical Co., Ltd. | Pharmaceutical compositions containing dds compounds |
US20040096569A1 (en) * | 2002-11-15 | 2004-05-20 | Barkalow David G. | Edible film products and methods of making same |
EP1428526A1 (en) * | 2002-12-13 | 2004-06-16 | Rijksuniversiteit Groningen | Formulation for fast dissolution of lipophilic compounds |
EP1514553A1 (en) * | 2003-09-05 | 2005-03-16 | Chung, Myung-jun | Lactic acid bacteria powder double-coated using protein and polysaccharide and method preparing the same and a dosage form thereof |
EP1501534B1 (en) * | 2002-05-07 | 2006-07-26 | Ferring BV | Desmopressin in an orodispersible dosage form |
EP1757279A1 (en) * | 2005-08-22 | 2007-02-28 | National Starch and Chemical Investment Holding Corporation | Dissolvable film |
WO2007143676A2 (en) * | 2006-06-05 | 2007-12-13 | Verus Pharmaceuticals, Inc. | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
US20090246257A1 (en) * | 2008-03-27 | 2009-10-01 | Pankaj Modi | Wafer formulation |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
JPS5446841A (en) * | 1977-08-16 | 1979-04-13 | Wellcome Found | Drug substituted hapten substance and production thereof |
CN1053808C (en) | 1993-04-24 | 2000-06-28 | 章修纲 | Nedepine quick releasing and slow releasing agent |
AU4052997A (en) | 1996-07-19 | 1998-02-10 | Clarke-Garegg, Margaret A. | Levan derivatives, their preparation, composition and applications including medical and food applications |
TW362041B (en) * | 1996-12-27 | 1999-06-21 | Asahi Chemical Ind | Leakage inspection apparatus and method for filter film |
EP0879600A1 (en) * | 1997-05-20 | 1998-11-25 | Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) | Fructan containing composition for the prevention and treatment of colon cancer |
EP0958825A1 (en) | 1998-05-18 | 1999-11-24 | Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) | Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer |
SE9803871D0 (en) | 1998-11-11 | 1998-11-11 | Pharmacia & Upjohn Ab | Therapeutic method and formulation |
AU1453600A (en) | 1998-11-04 | 2000-05-22 | Mcneil-Ppc, Inc. | Solid oral dosage forms containing alginic acid and famotidine |
GB9901819D0 (en) | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
NL1012300C2 (en) | 1999-06-11 | 2000-12-12 | Rijksuniversiteit | Stabilizer for pharmaceuticals. |
EP1064938A1 (en) | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
TR200200313T2 (en) | 1999-08-17 | 2002-04-22 | Novartis Consumer Health S.A. | Rapidly dissolving dosage form and its production process. |
WO2002003992A2 (en) | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for treating prosthesis-related bone degeneration |
MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
EP1492503B1 (en) | 2002-04-03 | 2008-11-12 | Solvay Pharmaceuticals B.V. | Stabilized natural cannabinoid formulation |
JP2006502972A (en) * | 2002-05-07 | 2006-01-26 | フェリング ベスローテン フェンノートシャップ | Orally dispersible pharmaceutical formulation of desmopressin |
US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
CA2516291C (en) | 2003-02-28 | 2012-02-14 | Alk-Abello A/S | Dosage form having a saccharide matrix |
CN100366294C (en) | 2004-04-30 | 2008-02-06 | 量子高科(北京)研究院有限公司 | Oral cavity quick dissolving preparation and production method thereof |
EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
CN100339081C (en) * | 2004-11-10 | 2007-09-26 | 范敏华 | Oral loratadine disintegrating tablet and its prepn |
BRPI0519212A2 (en) * | 2004-12-23 | 2009-01-06 | Mcneil Ppc Inc | oral disintegrating pharmaceutical compositions containing sensory manifestation agents |
US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
PL2347775T3 (en) * | 2005-12-13 | 2020-11-16 | President And Fellows Of Harvard College | Scaffolds for cell transplantation |
CN101636173A (en) * | 2007-03-27 | 2010-01-27 | 宝洁公司 | Methods and kits for administering probiotics |
CN101686942B (en) | 2007-06-27 | 2012-09-26 | 韩美药品株式会社 | Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same |
KR100930427B1 (en) * | 2008-01-25 | 2009-12-08 | 정명준 | Method for producing tri-coated lactic acid bacteria and nano-particle coating method, tri-coated lactic acid bacteria prepared by the method and products comprising the same |
CN102834091B (en) | 2010-03-29 | 2015-04-22 | 辉凌公司 | A fast dissolving pharmaceutical composition |
US20120135050A1 (en) | 2010-07-08 | 2012-05-31 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
-
2011
- 2011-03-28 CN CN201180017614.5A patent/CN102834091B/en active Active
- 2011-03-28 RU RU2012141140/15A patent/RU2566269C2/en not_active IP Right Cessation
- 2011-03-28 TW TW100110571A patent/TWI498132B/en active
- 2011-03-28 AU AU2011234637A patent/AU2011234637B2/en not_active Ceased
- 2011-03-28 MX MX2016007895A patent/MX350447B/en unknown
- 2011-03-28 MX MX2012011205A patent/MX341200B/en active IP Right Grant
- 2011-03-28 NZ NZ619857A patent/NZ619857A/en not_active IP Right Cessation
- 2011-03-28 EP EP11711321.7A patent/EP2552418B1/en active Active
- 2011-03-28 JP JP2013501780A patent/JP5736031B2/en active Active
- 2011-03-28 ES ES11711321.7T patent/ES2643087T3/en active Active
- 2011-03-28 US US13/636,758 patent/US8946153B2/en active Active
- 2011-03-28 CA CA2793485A patent/CA2793485A1/en not_active Abandoned
- 2011-03-28 NZ NZ706991A patent/NZ706991A/en not_active IP Right Cessation
- 2011-03-28 WO PCT/EP2011/054699 patent/WO2011120904A2/en active Application Filing
- 2011-03-28 KR KR1020127027214A patent/KR101790188B1/en active IP Right Grant
- 2011-03-28 NZ NZ602442A patent/NZ602442A/en not_active IP Right Cessation
- 2011-03-28 BR BR112012024432A patent/BR112012024432A2/en not_active IP Right Cessation
- 2011-03-28 CN CN201510034145.8A patent/CN104606128B/en active Active
- 2011-03-28 PL PL11711321T patent/PL2552418T3/en unknown
- 2011-03-29 AR ARP110101022A patent/AR080735A1/en unknown
- 2011-03-29 SA SA111320320A patent/SA111320320B1/en unknown
-
2012
- 2012-09-23 IL IL222087A patent/IL222087A/en not_active IP Right Cessation
- 2012-09-25 ZA ZA2012/07175A patent/ZA201207175B/en unknown
-
2013
- 2013-07-26 US US13/952,084 patent/US9096335B2/en active Active
-
2014
- 2014-12-16 US US14/571,883 patent/US10023335B2/en active Active
-
2016
- 2016-08-02 IL IL247079A patent/IL247079A0/en unknown
-
2018
- 2018-06-16 US US16/010,412 patent/US20180297728A1/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1308171A1 (en) * | 2000-07-13 | 2003-05-07 | Daiichi Pharmaceutical Co., Ltd. | Pharmaceutical compositions containing dds compounds |
US6509040B1 (en) * | 2001-06-22 | 2003-01-21 | R.P. Scherer Corporation | Fast dispersing dosage forms essentially free of mammalian gelatin |
EP1501534B1 (en) * | 2002-05-07 | 2006-07-26 | Ferring BV | Desmopressin in an orodispersible dosage form |
US20040096569A1 (en) * | 2002-11-15 | 2004-05-20 | Barkalow David G. | Edible film products and methods of making same |
EP1428526A1 (en) * | 2002-12-13 | 2004-06-16 | Rijksuniversiteit Groningen | Formulation for fast dissolution of lipophilic compounds |
EP1514553A1 (en) * | 2003-09-05 | 2005-03-16 | Chung, Myung-jun | Lactic acid bacteria powder double-coated using protein and polysaccharide and method preparing the same and a dosage form thereof |
EP1757279A1 (en) * | 2005-08-22 | 2007-02-28 | National Starch and Chemical Investment Holding Corporation | Dissolvable film |
WO2007143676A2 (en) * | 2006-06-05 | 2007-12-13 | Verus Pharmaceuticals, Inc. | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
US20090246257A1 (en) * | 2008-03-27 | 2009-10-01 | Pankaj Modi | Wafer formulation |
Non-Patent Citations (1)
Title |
---|
BEINE R ET AL: "Directed optimization of biocatalytic transglycosylation processes by the integration of genetic algorithms and fermentative approaches into a kinetic model", PROCESS BIOCHEMISTRY, ELSEVIER, NL, vol. 44, no. 10, 1 October 2009 (2009-10-01), pages 1103 - 1114, XP026565187, ISSN: 1359-5113, [retrieved on 20090611], DOI: 10.1016/J.PROCBIO.2009.06.001 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011120904A3 (en) | A fast dissolving pharmaceutical composition | |
SA112330855B1 (en) | A fast dissolving pharmaceutical composition | |
EP2522653A4 (en) | Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient | |
IL249141A0 (en) | Parasiticidal compositions comprising multiple active agents, methods and uses thereof | |
EP2657231A4 (en) | Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof | |
WO2011120903A3 (en) | A fast dissolving pharmaceutical composition | |
EP3216448B8 (en) | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof | |
KR20180085042A (en) | Bismuth-thiols as antiseptics for agricultural, industrial and other uses | |
EP2394986A4 (en) | 3-aminoxalylaminobenzamide derivatives, and insecticidal and miticidal agents containing same as active ingredient | |
WO2009135593A3 (en) | Solid pharmaceutical formulation with delayed release | |
ZA201303116B (en) | Imine substituted 2,4-diaryl-pyrroline derivatives as pesticides | |
IL225440A (en) | Cyclohexane derivatives, compositions comprising the same and uses thereof | |
EP2476420B8 (en) | Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same | |
WO2009054483A1 (en) | Drug containing salusin-β | |
Oladele | The Emergence of Social Networks on the Web as New Marketing Tools | |
苗曙光 | Conflict Management in the Application of Project Cost Management | |
高慧然 | I See You | |
严寒 | Gattungsanalyse Der Chinesischen Verabredungs-SMS | |
Makofsky | Two New Artists Of New China | |
UA72107U (en) | Dosage form of licopen | |
WO2011020909A3 (en) | Cis-3-cyclopentylcyclohexanol and its use as a fragrance ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180017614.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11711321 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2793485 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011234637 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 222087 Country of ref document: IL |
|
REEP | Request for entry into the european phase |
Ref document number: 2011711321 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011711321 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 8432/DELNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/011205 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013501780 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2011234637 Country of ref document: AU Date of ref document: 20110328 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20127027214 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012141140 Country of ref document: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13636758 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012024432 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012024432 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120926 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 247079 Country of ref document: IL |